Intelligence · Clinical pipeline
Oncology · Approved programs
Oncology programs at Approved programs — ClinicalTrials.gov pipeline intelligence.
Quick answer
Oncology Approved programs programs: NovaPharmaNews indexes 124 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- First People's Hospital 19 programs
- Disc Medicine 18 programs
- Chinese Academy of 16 programs
- George Institute for 8 programs
- Novartis India 6 programs
- Takeda 6 programs
- HOFFMANN-LA ROCHE 4 programs
- Telethon Foundation 4 programs
- Pfizer 3 programs
- AstraZeneca 2 programs
- Eli Lilly and 2 programs
- First Biotech (Australia) 2 programs
Pipeline programs
-
Fentanyl Buccal Tablet (FBT)
Teva Pharma GmbH
Cancer Pain
1 trial -
Fruquintinib
Takeda
Colorectal Cancer
1 trial -
GAVRETO ®(pralsetinib) capsules
RIGEL PHARMACEUTICALS INC
Patients with advanced or metastatic solid tumors
1 trial -
GEICAM/2023-09
Ningbo Cancer Hospital
Early Breast Cancer
1 trial -
Gadoterate meglumine
Guerbet
Hepatocellular Carcinoma
1 trial -
INDOCYANINE GREEN
Disc Medicine
cervical cancer stage I-IIA
1 trial -
INDOCYANINE GREEN
The George Institute
Patients with liver tumors that will undergo minimally invasive liver surgery
1 trial -
ITALIC-RCC
Fondazione Telethon ETS
metastatic or locally advanced renal cell carcinoma
1 trial -
Ibrutinib
AbbVie Deutschland GmbH & Co. KG
1. Follicular Lymphoma 2. Chronic Lymphocytic Leukemia 3. Waldenstrom macroglobulinemia 4. Multiple Myeloma 5. Marginal Zone Lymphoma 6. Diffuse Large B-Cell Lymphoma 7. Urothelial Carcinoma 8. Breast Cancer 9. Acute Myeloid Leukemia 10. Graft vs Host Disease 11. Mantle Cell Lymphoma
1 trial -
Ilaprazole
Yang Xiaotian
Gastric Cancer
1 trial -
Intrathecal (injected into the spinal fluid) DepoCyt
Pacira Ireland Limited
Meningeal Neoplasms
1 trial -
Iomeron 400 mgI/ml solution for injection
The George Institute
Thoracic neoplasm
1 trial -
Irinotecan liposomes combined with cisplatin/carboplatin
The First People's Hospital of Lianyungang
Neuroendocrine Tumors
1 trial -
Jejunostomy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Cancer
1 trial -
KANG FU PEN
The First People's Hospital of Lianyungang
Cervical Cancer
1 trial -
LORLATINIB
Pfizer Australia Pty Ltd
Lung cancer
1 trial -
Ledipasvir 90mg/Sofosbuvir 400 mg
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hepatocellular Carcinoma
1 trial -
METHADONE for Opioid use disorder (DSM-5); ch…
Disc Medicine
Opioid use disorder (DSM-5); chronic non-cancer pain (ICD-11).
1 trial -
MK-7902-015
Merck Sharp and Dohme
Advanced/Metastatic Gastroesophageal Adenocarcinoma
1 trial -
MORPHINE for Prostate cancer
Disc Medicine
Prostate cancer
1 trial -
MedPulser Electroporation with bleomycin
INOVIO PHARMACEUTICALS, INC.
Cancer
1 trial -
Medpulser electroporation with Bleomycin
INOVIO PHARMACEUTICALS, INC.
Head and Neck Cancer
2 trials -
NIVOLUMAB
Disc Medicine
Melanoma, Renal cell carcinoma
1 trial -
Niraparib
Takeda
Epithelial Ovarian Cancer
1 trial -
OBU-BC-II-206
The First People's Hospital of Lianyungang
HER2 Positive Breast Cancer
1 trial -
ONTAK (denileukin difitox, DAB389IL-2)
LIGAND PHARMACEUTICALS INC
Lymphoma, T-Cell, Cutaneous
1 trial -
OROS hydromorphone
Janssen Cilag International NV
Cancer Pain
1 trial -
OXALIPLATIN, CAPECITABINE
Disc Medicine
Locally advanced or metastatic gastro-intestinal carcinoma
1 trial -
Olutasidenib
RIGEL PHARMACEUTICALS INC
AML (Acute Myeloid Leukemia)
1 trial -
Oral prednisolone (30mg/day) for 28 days
Hospital Authority, Hong Kong
Esophageal Neoplasms
1 trial -
PEG-rhG-CSF
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Cervical Cancer
1 trial -
PHARBEVACOL
Tour Hekla
1st line treatment for unresectable metastatic colorectal cancer
1 trial -
Pegylated liposomal doxorubicin
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Pembrolizumab
Merck KGaA, Darmstadt, Germany
Carcinoma, Non-Small-Cell Lung
1 trial -
Pluvicto 1 000 MBq/mL solution for injection/infusion
Novartis Pharmaceuticals
Prostate cancer
1 trial -
Pregabalin
Pfizer
Bone Neoplasms
1 trial -
Providence
The George Institute
Cervical cancer
1 trial -
RADAR-1 CRPC
Fondazione Telethon ETS
metastatic castration resistant prostate cancer without mutations of BRCA1/2 genes or unknown
1 trial -
RIBOCICLIB, Kisqali 200 mg film-coated tablets
The George Institute
Hormone receptor–positive (HRpos)/human epidermal growth factor receptor 2–negative (HER2neg) early breast cancer at risk of recurrence
1 trial -
Raltitrexed
The First People's Hospital of Lianyungang
Head and Neck Squamous Cell Carcinoma
1 trial -
Realgar-Indigo Naturalis Formulation Combined with Anlotinib
The First People's Hospital of Lianyungang
Platinum-resistant Ovarian Cancer (PROC)
1 trial -
Recombinant Human Adenovirus Type 5 injection
The First People's Hospital of Lianyungang
Hepatocellular Carcinoma
1 trial -
Ribociclib
Novartis Pharmaceuticals
Metastatic Breast Cancer
1 trial -
S-1
The First People's Hospital of Lianyungang
Pancreatic Cancer
1 trial -
SELECTIO-UC
Fondazione Telethon ETS
metastatic or locally advanced urothelial cancer
1 trial -
SELPERCATINIB, SELPERCATINIB
Eli Lilly Co.
Non Small Cell Lung Cancer; Medullary Thyroid Cancer; Colon Cancer; Breast Cancer; Pancreatic Cancer; Papillary Thyroid Cancer; Other Solid Tumors With Evidence of Activating RET Alteration;
1 trial -
SIS-reinforced anastomosis
Rocket Pharmaceuticals B.V.
Rectal Cancer
1 trial -
Sequential Icotinib Plus Chemotherapy
Betta Pharmaceuticals Co.,
EGFR Positive Non-small Cell Lung Cancer
1 trial
Frequently asked questions
How many oncology Approved programs programs exist?
124 programs match both the therapeutic area and stage filters in our published index.